Skip Navigation

FP-3.1 Data Details

FP-3.1 Increase the proportion of publicly funded family planning clinics that offer the full range of FDA-approved methods of contraception onsite

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
53.6 (2010)
Target
67.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of publicly funded family planning clinics that reported offering all FDA-approved methods of contraception onsite
Denominator
Number of publicly funded family planning clinics
Questions Used to Obtain the National Baseline Data

From the 2010 Survey of Contraceptive Service Providers:

[NUMERATOR:]

For each of the following methods of contraception, indicate whether:

  1. The method/service is provided or prescribed at this site
  2. Clients are referred to another clinic/provider within your agency/organization for this method/service
  3. Clients are referred to a clinic/provider that is not affiliated with your agency/organizatino for this method/service
  4. The method/service is not provided and referrals are not given
      1. Oral Contraceptives (OCs)
      2. Extended OC regimen (Seasonale, Seasonique)
      3. IUD: Mirena
      4. IUD: Paragard (Copper-T)
      5. Injectable (Depo-Provera)
      6. Patch (Ortho Evra)
      7. Vaginal ring (NuvaRing)
      8. Diaphram, cervical cap (Lea's Shield, FemCap)
      9. Sponge (Today)
      10. Male condom
      11. Female condom
      12. Spermicides
      13. Natural family planning (NFP) instruction
      14. Emergency contraception
      15. Female sterilization (Tubal ligation, Tubal ligation (Essure))
      16. Vasectomy
Data Collection Frequency
Periodic
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

Family planning clinics are considered to have offered the full range of FDA-approved contraceptive methods if they offered all methods that, at the time of data collection, were available in the United States and had been approved by the FDA for at least three years. Using 2010 data as the baseline for this measure, clinics are considered to have offered the full-range of FDA approvedcontraceptive methods if they offered all of the following methods onsite: oral contraceptives, long-acting reversible contraception (IUD or implant), injectable (Depo-Provera), other hormonal methods (patch or ring), male barrier (condom), female barrier (diaphragm or cervical cap or sponge or female condom or spermicides), and emergency contraception. Methods not approved by the FDA for at least three years are not included in the numerator in order to give clinics a reasonable amount of time after a method is approved to update their clinic protocols and purchasing arrangements.

The Guttmacher Institute conducts a periodic survey of agencies and clinics providing subsidized family planning services in the United States and its jurisdictions. Data for this objective are derived from the periodic survey of family planning clinics (including Title X-funded clinics, health departments, hospitals, community health centers, independent clinics, and Planned Parenthood clinics).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline data and baseline year were revised from 38.3% and 2003 to 56.6% and 2010 as a result of changes in methodology.